» Authors » Johan Franck

Johan Franck

Explore the profile of Johan Franck including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 1466
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bach P, Franck J, Hallgren J, Widing H, Gissler M, Westman J
Eur Arch Psychiatry Clin Neurosci . 2025 Mar; PMID: 40072533
Data on the comparative usefulness of medications commonly prescribed to individuals with alcohol use disorder (AUD) are scarce. This study compared the association between antidepressants, relapse-preventive AUD medication, both, and...
2.
Hong M, Khemiri L, Guterstam J, Franck J, Jayaram-Lindstrom N, Melas P
Pharmacol Rep . 2025 Mar; PMID: 40069537
Background: OSU6162, a monoamine stabilizer, has demonstrated efficacy in reducing alcohol and anxiety-related behaviors in preclinical settings. In a previous randomized, double-blind, placebo-controlled trial involving patients with alcohol dependence (AD),...
3.
Brynte C, Schellekens A, Barta C, Begeman A, Crunelle C, Daigre C, et al.
J Clin Psychiatry . 2024 Dec; 86(1). PMID: 39724095
Treatment of attention-deficit/ hyperactivity disorder (ADHD) in patients with a substance use disorder (SUD) and comorbid ADHD (SUD +ADHD) may have positive effects on the outcome of both conditions, but...
4.
Burmester S, Kruger C, Hallgren J, Westman J, Franck J
BMC Psychiatry . 2024 Dec; 24(1):937. PMID: 39707239
Background: There is limited knowledge on long-term outcomes of tapering treatment for individuals with problematic use of prescription narcotics, including opioids and benzodiazepines. The overall aim of the study is...
5.
Burmester S, Kruger C, Franck J, Lindberg M, Westman J
J Subst Use Addict Treat . 2024 Sep; 167:209508. PMID: 39243978
Introduction: Addiction to benzodiazepines is a serious problem, and it is important to better understand how individuals can be motivated to quit. Few studies have investigated patients' perceptions and experiences...
6.
Gaber S, Franck J, Widing H, Hallgren J, Mattsson E, Westman J
J Epidemiol Community Health . 2024 May; 78(8):473-478. PMID: 38772698
Background: People in homelessness have an increased risk of substance use disorders (SUDs) and poor health outcomes. This cohort study aimed to investigate the association between homelessness and mortality in...
7.
Kane K, Westman J, Franck J, Gissler M
J Epidemiol Community Health . 2024 Apr; 78(7):444-450. PMID: 38688702
Background: Growing up with parental alcohol use disorder (AUD) is a risk factor for psychiatric disorders. This study investigated the risk of mood disorders and of anxiety disorders in the...
8.
Romero D, Rozental A, Carlbring P, Johansson M, Franck J, Berman A, et al.
Psychol Addict Behav . 2024 Apr; 38(8):879-890. PMID: 38635201
Objective: Most individuals attending detoxification clinics do not pursue subsequent treatment. Earlier research has suggested that emerging technologies like mHealth interventions could address the postdetoxification treatment gap, yet it remains...
9.
Brynte C, Konstenius M, Khemiri L, Backer A, Guterstam J, Levin F, et al.
Eur Addict Res . 2023 Nov; 30(1):1-13. PMID: 38029734
Introduction: Attention deficit/hyperactivity disorder (ADHD) with co-occurring substance use disorder (SUD) is associated with poor treatment outcomes. Two randomized controlled trials, utilizing robust doses of stimulants, demonstrated a significant effect...
10.
Brynte C, Khemiri L, Stenstrom H, Konstenius M, Lindstrom N, Franck J
BMC Psychiatry . 2023 Jul; 23(1):537. PMID: 37488536
Background: Amphetamine use disorder (AMPH) and attention deficit-hyperactivity disorder (ADHD) often co-occur and are associated with poor treatment outcomes. Elevated impulsivity is a core feature in both disorders. Little is...